Qiagen Stock price Nasdaq
Equities
NL0012169213
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 2.01B | Sales 2025 * | 2.16B | Capitalization | 9.77B |
---|---|---|---|---|---|
Net income 2024 * | 397M | Net income 2025 * | 446M | EV / Sales 2024 * | 5 x |
Net Debt 2024 * | 303M | Net cash position 2025 * | 281M | EV / Sales 2025 * | 4.4 x |
P/E ratio 2024 * |
24.9
x | P/E ratio 2025 * |
21.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.49% |
Latest transcript on Qiagen
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
1st Jan change | Capi. | |
---|---|---|
+9.72% | 46.21B | |
+34.27% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B |